{"disease":{"id":"left-ventricular-thrombus","name":"Left ventricular thrombus","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:31:21.551Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":0,"pipeline_drug_count":1,"trial_count":0},"drugs":{"marketed":[],"pipeline":[{"drug_id":"oral-anticoagulant","indication_name":"Left ventricular thrombus","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Oral Anticoagulant","generic_name":"oral-anticoagulant","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"Factor Xa (coagulation Factor X, activated form)","drug_class":"Direct oral anticoagulant (DOAC); Factor Xa inhibitor","quality_score":31,"revenue":null,"mechanism":"Inhibits Factor Xa to block the intrinsic and extrinsic coagulation pathways, preventing thrombin generation and clot formation."}],"offLabel":[],"totalMarketed":0,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT05077683","title":"Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":560,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06742567","title":"Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":472,"lead_sponsor_name":"National Institute of Cardiovascular Diseases, Pakistan","has_results":false},{"nct_id":"NCT04871126","title":"Predictive Value of Inflammatory Indexes and CHA2DS2-VASc Score for LVT in ANT-MI With Left Ventricular Dysfunction","phase":"","overall_status":"COMPLETED","enrollment_count":371,"lead_sponsor_name":"Henan Provincial People's Hospital","has_results":false},{"nct_id":"NCT05892042","title":"Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction","phase":"NA","overall_status":"UNKNOWN","enrollment_count":320,"lead_sponsor_name":"Jilin University","has_results":false},{"nct_id":"NCT03764241","title":"Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":280,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT04970576","title":"Rivaroxaban in Left Ventricular Thrombus","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":261,"lead_sponsor_name":"National Institute of Cardiovascular Diseases, Pakistan","has_results":false},{"nct_id":"NCT06515730","title":"Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":212,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT03786757","title":"Prevention of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant (EARLYmyo-LVT Ⅱ)","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT05973188","title":"Safety and Efficacy of Rivaroxaban and Apixaban in Comparison to Warfarin in Left Ventricular Clot- Clinical Trial","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":141,"lead_sponsor_name":"Peshawar Institute of Cardiology","has_results":false},{"nct_id":"NCT07246005","title":"LVT DURATION: Pilot Study of Anticoagulation Duration for Left Ventricular Thrombus","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Queen Mary University of London","has_results":false},{"nct_id":"NCT04829825","title":"The \"MyoThrombus\" Study","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"University of Edinburgh","has_results":false},{"nct_id":"NCT05705089","title":"Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Rajaie Cardiovascular Medical and Research Center","has_results":false},{"nct_id":"NCT05208398","title":"Apixaban in Patients With Left Ventricular Thrombus","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Saud Al Babtain Cardiac Center","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}